$PNNX: Pennexx Reports That It Has Doubled Its Revenue for

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
337
$PNNX: Pennexx Reports That It Has Doubled Its Revenue for the Fourth Quarter 2020 and Has Commitments for Revenue for 2021 and 2022

Philadelphia, PA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire– Pennexx (PNNX) reports it has increased its revenue for the fourth quarter of this year and has a commitment for additional revenue avenues going into 2022.

This news represents a significant milestone for the company regarding its continuous commitment to increasing shareholder value, increasing its revenue, and building a strong foundation for its business.

Fourth quarter revenue has approximately doubled in comparison to the third quarter. Pennexx has opened the door to the possibility of a significant revenue increase for 2021.

Vincent Risalvato, CEO of Pennexx, said, "We are feeling optimistic to see this rapid growth and revenue this quarter. I attribute Pennexx's growth to our hard-working team who are diligent and dedicated to the health of Pennexx, YSO, and its shareholders."

Pennexx's revenues are earmarked for paying expenses, building YSO technology and its brand.

Pennexx's primary financial goal is to catapult it to a social media marketing success. Joe Candito, President of Pennexx, said, "Pennexx has a diverse number of ways they can collect revenue. Our team is building those revenue streams and building a sales team through partnerships and commission-based agreements. Our aggressive commission structure is attractive for partners with a proven track record of sales growth."

Pennexx's revenue streams include subscription fees, commission on influencer sales, a percentage of discount offers, advertising fees, development fees, as well as others.

According to https://www.investopedia.com/articles/stocks/...lities.asp, "Stable earnings, return on equity (ROE), and their relative value compared with those of other companies are timeless indicators of the financial success of companies that might be good investments."

Vincent Risalvato says, "We are in a growth stage, hoping to quickly transition to a point as soon as next year where we may see an ROE and possibly a dividend to our shareholders. Earning money for our shareholders is one of our goals for the company, and I believe it is very achievable."

For More Information

Pennexx will do their best to openly and publicly answer your questions and concerns via social media on Twitter https://twitter.com/pennexx @pennexx or you may email investors@pennexx.net.

You may also follow them on Twitter; Ms. Sunny Sweet (@sunnysweettweet) https://twitter.com/sunnysweettweet, Mr. Risalvato (@vrisalvato) https://twitter.com/vrisalvato and Joe Candito (@jcandito) https://twitter.com/jcandito.

About Pennexx Foods Inc.

About Pennexx Foods Inc. (PNNX: OTCMKTS US). Pennexx, through its wholly-owned subsidiaries, is a holding company within the Software/Internet Industry focused on social media, prepaid debit cards, BitGift™, artificial intelligence, targeted marketing, and consumer rewards.

Safe Harbor Act: This release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.

For additional information, you may also visit our website at https://yoursocialoffers.com or https://pennexx.net or call 866-928-6409. Please follow us on Twitter @Pennexx.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Experience Hassle-Free Cloud Mining with BCC Mining's App

Updated Category News Views 248

Revolutionizing Cloud Mining with BCC Mining Cloud mining has witnessed significant advancements, particularly with the recent introduction of BCC Mining's mobile app. This development marks a new era for cryptocurrency enthusiasts, making it easier than ever to participate in mining activities. Users now have the flexibility to manage their mining operations from...

Continue Reading
CEFALY Launches Research Registry for Pregnant Women’s Migraine Relief

Updated Category News Views 197

CEFALY Introduces the Pregnancy Registry for Migraine Treatment Medical device company CEFALY Technology has recently announced the introduction of the CEFALY Pregnancy Registry, a research initiative aimed at assessing the safety of external trigeminal nerve stimulation (eTNS) for migraine treatment during pregnancy. The Challenge of Managing Migraines During Pregnancy...

Continue Reading
Velocity MSC Expands Offerings with Innovative 5G Communication Solution

Updated Category News Views 234

Velocity MSC Expands Offerings with Innovative 5G Communication Solution Velocity MSC, a trusted name in technological solutions, has announced an exciting addition to its service lineup. The company has incorporated DataRemote's advanced 90X1 5G Plain Old Telephone Service (POTS) replacement solution into its existing offerings. This innovative solution aligns with...

Continue Reading
Exploring the Growth of Interleukin-23 Inhibitors Market Ahead

Updated Category News Views 148

Interleukin-23 Inhibitors Market Overview The interleukin-23 inhibitors market is currently experiencing significant growth, fueled by the escalating prevalence of autoimmune diseases such as psoriasis and inflammatory bowel disease. With innovations in biologics and increasing acceptance of targeted therapies, the demand for these treatments continues to surge....

Continue Reading
Hexagon AB to Spin Off Asset Lifecycle Intelligence Division

Updated Category News Views 671

Hexagon Plans Spin-Off for Enhanced Focus and Growth Hexagon AB is embarking on an exciting journey towards the spin-off of its Asset Lifecycle Intelligence (ALI) division and associated businesses. This significant decision, made by the Board of Directors, aims to separate ALI into a new entity that will allow both Hexagon and the new organization, referred to as NewCo,...

Continue Reading